Skip to main content
PLOS One logoLink to PLOS One
. 2022 Dec 19;17(12):e0277618. doi: 10.1371/journal.pone.0277618

Central catheter tip migration in critically ill patients

Roei Merin 1,*, Amir Gal-Oz 1, Nimrod Adi 1, Jacob Vine 1, Reut Schvartz 1, Reut Aconina 2, Dekel Stavi 1
Editor: Martin Kieninger3
PMCID: PMC9762564  PMID: 36534662

Abstract

Objectives

Chest X-ray (CXR) is routinely required for assessing Central Venous Catheter (CVC) tip position after insertion, but there is limited data as to the movement of the tip location during hospitalization. We aimed to assess the migration of Central Venous Catheter (CVC) position, as a significant movement of catheter tip location may challenge some of the daily practice after insertion.

Design and settings

Retrospective, single-center study, conducted in the Intensive Care and Cardiovascular Intensive Care Units in Tel Aviv Sourasky Medical Center ’Ichilov’, Israel, between January and June 2019.

Patients

We identified 101 patients with a CVC in the Right Internal Jugular (RIJ) with at least two CXRs during hospitalization.

Measurements and results

For each patient, we measured the CVC tip position below the carina level in the first and all consecutive CXRs. The average initial tip position was 1.52 (±1.9) cm (mean±SD) below the carina. The maximal migration distance from the initial insertion position was 1.9 (±1) cm (mean±SD). During follow-up of 2 to 5 days, 92% of all subject’s CVCs remained within the range of the Superior Vena Cava to the top of the right atrium, regardless of the initial positioning.

Conclusions

CVC tip position can migrate significantly during a patient’s early hospitalization period regardless of primary location, although for most patients it will remain within a wide range of the top of the right atrium and the middle of the Superior Vena Cava (SVC), if accepted as well-positioned.

Background

Central Venous Catheterization (CVC) is a common procedure in intensive care units (ICU), operating rooms (OR), and other hospital departments such as the emergency department or in other cases where peripheral venous access is difficult to obtain (e.g. oncology or hematology). It is estimated that in the United States alone 5 million CVCs are inserted each year [1, 2]. In most cases within the ICU, a routine chest X-Ray (CXR) is obtained after insertion in order to detect insertion-related complications and to assess catheter tip position. In most cases using the CVC is allowed only after the CXR is conducted.

With the increasing use of ultrasound (US) in guiding CVC insertion as opposed to anatomical landmarks alone, there has been a decrease in insertion-related complications, mainly pneumothorax, and vascular bleeding [3, 4]. In addition, the use of bedside-US has been shown to be faster and more accurate compared to CXR in detecting these complications when they occur [2, 5, 6]. For these reasons, currently, the assessment of CVC tip position remains the main rationale for routine CXR before usage when performing US assisted CVC insertion.

Malposition of the tip can potentially lead to CVC-related complications. Proximal positioning has been related to a higher risk of venous thrombosis, while distal positioning in the right atrium or in the right ventricle can cause cardiac arrhythmias and tamponade, although late cardiac tamponade as a complication of deep catheter tip location has been described as an “urban legend” [1, 79]. Nevertheless, proper positioning of CVC tip is a subject of controversy in the literature and is based on outdated guidelines [10]. Several past studies accept only a narrow area for proper tip positioning, usually in the lower part of the Superior Vena Cava (SVC)- an area of 2–3 cm long below the Carina (see zone A in Fig 1) [1, 6, 11, 12], while others allow a much larger area for tip positioning: from the upper part of the SVC to the right atrium [10, 1319] (Zone A and B as depicted in Fig 1). Whether a tip located in the right atrium (RA) is accepted is also a matter of controversy [10, 11]. Regardless of tip position after insertion, the CVC is often left unchanged due to the likelihood of complications associated with CVC repositioning [19, 22].

Fig 1. Relationship between the Superior Vena Cava and the carina.

Fig 1

Although there is much discussion regarding assessment of post insertion primary tip location, the migration of tip position during hospitalization is not routinely examined and has not been well described in previous literature. The importance of tip position migration in the following days post insertion is unknown and it is not clear how this issue should be addressed, if at all.

This study aims to determine the migration of CVC tip location during hospitalization, as significant movement can challenge traditional approach.

Material and methods

This is a retrospective observational study conducted in the Intensive Care and Cardiovascular Intensive Care Units in Tel Aviv Sourasky Medical Center ’Ichilov’, Israel. We examined all patients from our EMR (electronic medical records) hospitalized between January to June 2019 in the general Intensive Care Unit (ICU) and Cardiovascular Intensive Care Unit (CVICU). In both units, a 15 cm long CVC is routinely inserted using a US-guided technic by anesthesiologists and intensive care physicians all trained in the same critical care and anesthesia program. Patients were included if they were aged over 18, had their CVC inserted from the Right Internal Jugular (RIJ), and had at least two CXRs showing the CVC’s position during their hospitalization. Only RIJ catheters were included in order to minimize diversity regarding insertion sites. We identified 162 patients who met the inclusion criteria. Patients under the age of 18, hospitalized for less than 24 hours, patients in a prone position, pregnant individuals, and patients undergoing dialysis were excluded from the study. In addition, we excluded patients who underwent another cardio-vascular or thoracic surgery or moved between wards during the time of the study in order to minimize these effects on CVC location. The ethical committee has waived the need for informed consent.

For each patient, the time of CVC insertion was noted. We then analyzed the post-procedure CXR to determine the primary catheter tip position. Using "Vue Motion" software (PHILIPS, Version 12, software for picture archiving and communication) the vertical distance between the carina and the tip location was used as a standardized method to describe the position of the catheter tip on CXR (as shown in Fig 2). Next, we applied the same method on every following CXR performed while the CVC was still inserted and untouched, up to 4 CXRs for each patient. In our facility in the early days of intensive care hospitalization, a CXR is performed every one or two days, so a follow-up time of up to 5 days from CVC insertion was selected. CXRs were examined by two different ICU physicians/trainees who were qualified for this routine procedure: R.M and J.V. In any case of disagreement up to 1 cm, the average between the two investigators was used. In any other case, a third investigator (D.S) examined the CXR.

Fig 2. Measuring the vertical distance from carina to catheter tip.

Fig 2

In all cases, we noted CVC insertion time, time of each CXR, patient’s position during CXR (supine/sitting/standing), department in which CVC was inserted (ICU/CVICU), and patient’s demographic data (sex, age, height, weight).

We used the definition for ‘correct’ CVC tip position as the lower part of the SVC, 1–3 cm below the carina, based on guidelines published in 2016 [20]. Catheter tip positioned inside this range on CXR was defined as well-positioned, otherwise, it was defined as malpositioned. We calculated the average movement between two consecutive CXRs and the maximal distance between the initial tip position and the tip position on follow-up CXRs.

All data were analyzed using SPSS version 21.0. Continuous data are described as mean ± SD (standard deviation) and categorical variables are given as no. (%) continuous variables were compared using a two-sided T-test, P_value <0.05 was considered to be statistically significant. Data was proved for normal distribution before performing T-test. Multivariant analysis was performed using linear regression as the main outcome variable is catheter tip migration. Change in CVC position (well-position or malposition) between follow up CXRs was analyzed in a descriptive approach using percentage of CVCs compared to initial position.

Results

We identified 162 patients who had a CVC inserted in the study period. 13 patients (9%) had only one CXR showing the CVC position. Out of the remaining 149 patients, 48 (29%) had a CVC inserted in a position different than the RIJ. 101 patients met the inclusion criteria for the study. All CVCs were inserted according to the institutional guidelines and were secured similarly using skin stitches and dressing. Demographic data are shown in Table 1.

Table 1. Patient characteristics, compared between initially well-positioned and malpositioned CVCs according to CXR after insertion.

Total (n = 101) well-positioned Catheter tip in the first CXR (n = 46) malpositioned Catheter tip in the first CXR (n = 55) P.Value
Age, years mean (SD) 63.1 (11.3) 64.04(10.1) 62.38(12.2) 0.45
Female sex, n (%) 25 (25%) 10 (22%) 15(27%) 0.48
Height, m mean (SD) 1.7 1.71 (0.09) 1.69 (0.07) 0.086
Weight, Kg mean (SD) 79.96 (18.97) 79.1 (16.32) 80.1 (20.9) 0.28
BMI mean (SD) 27.7(5.9) 27.8(6.6) 27.6(5.1) 0.18
Unit
ICU, n (%) 51 21 (41%) 30 (59%) 0.315
CVICU, n (%) 50 25 (50%) 25(50%) 0.5

CXR- Chest X-ray; SD- standard deviation; BMI- Body Mass Index; ICU- Intensive Care Unit; CVICU- Cardiovascular Intensive Care Unit.

In 100 patients of a total of 101 patients (99%) the CVC was inserted into the SVC, and 1 CVC (1%) was inserted from the RIJ and ended in the Right Subclavian. For the remaining 100 patients, CVC position was measured in the initial CXR and was followed in the consecutive CXR during hospitalization: 12 patients had one follow up CXR before CVC extraction, 41 patients had 2 CXR’s and 47 had 3 CXRs follow up. The average follow up time was 2.6 days (range 2–5 days). Average time from insertion to first CXR was 3 hours. In the first CXR assessment after CVC insertion, 46 CVC tips were positioned inside the lower part of the SVC (well-positioned), and 54 CVC tips were positioned either deeper or higher than that range (malpositioned). Of the 46 CVCs that were initially well-positioned, 22 (48%) remained well-positioned in the second CXR and only 8 (17%) remained well-positioned in all CXRs during hospitalization. In 15% of CXR’s defining the tip position was difficult due to reduced x-ray quality, and additional examination by ICU specialist was needed. Table 2 shows the follow-up of initially well positioned and initially malposition CVCs according to the 2nd 3rd and 4th CXRs.

Table 2. Catheter tip positioning movement during hospitalization as shown in consecutive CXRs compared to initial position (1st CXR).

Total Well-position of catheter tip Malposition of catheter tip
1st CXR Well positioned Catheter tip 46 100%
2nd CXR 46 22(48%) 24 (52%)
3rd CXR 41 20 (49%) 21 (51%)
4th CXR 27 11(40%) 16(60%)
1st CXR malpositioned Catheter tip 54 100%
2nd CXR 54 21(39%) 33(61%)
3rd CXR 47 12(26%) 35(74%)
4th CXR 20 10(50%) 10(50%)

CXR- Chest X-ray.

Catheter location movement during hospitalization

The initial average CVC position was 1.5 (±1.9) cm (mean±SD) below the Carina level. The highest position was 4.6 above, and the deepest was 5.5 cm below the Carina level. The average movement of CVC between two consecutive CXRs (around 24h) was 1.1 cm (±0.7) (mean±SD), and the maximal distance from the initial insertion position was 1.9 (±1) cm (mean±SD). There were no significant differences in CVC movement comparing initially well-positioned and malpositioned catheters (1.12 for wellpositioned and 1.08 for malpositioned, p_value 0.4).

Figs 3 and 4 present the movement of CVC tip during hospitalization for patients with four CXRs, a total of 47 patients. The “well positioned” zone, between 1–3 cm below the carina, is shown in red. Fig 3 presents patients with CVC who were initially well positioned, and Fig 4 presents patients initially malpositioned. At each follow-up CXR, the chance of an initially well-positioned and initially malpositioned catheter to be in the “well positioned" zone was as follows: 48% vs 39% at first CXR, 49% vs 26% at second, and 40% vs 50% at third CXR.

Fig 3. Tip position below the carina as shown in CXR (after insertion, 1st, 2nd, and 3rd) for initially well-positioned catheters.

Fig 3

CVC (Central Venous Catheter), h(Hour). CVC- Central Venous Catheter.

Fig 4. Tip position below the carina as shown in CXR (after insertion, 1st, 2nd, and 3rd) for initially mal-positioned catheters.

Fig 4

CVC (Central Venous Catheter), h(Hour).

When assessing tip location using a wider range for well-positioning, Figs 3 and 4 above show that most catheters regardless of initial position, remain between 1.5 cm above the carina to 5 cm under it. Only four CVCs (8%) were documented out of this range during use. All of these were in patients with BMI> 40 or height<1.55 m.

In a multi-parameters regression model (Table 3), we assessed for parameters related to CVC movement. Patient’s BMI (P_value = 0.03) and patient’s position change between CXRs (P_vaule = 0.04) were both statistically significant in correlation to CVC tip movement. Patient’s age (P_value = 0.08) and sex (P_value = 0.4) did not affect the average movement.

Table 3. Multiparameter regression analysis of CVC tip movement between two consecutive CXRs.

BMI Position change Mean movement (min) = (max) =
20 no 1.083 .198 1.968
20 yes 1.377 .205 2.548
25 no 1.187 .206 2.167
25 yes 1.481 .214 2.747
30 no 1.291 .215 2.367
30 yes 1.584 .223 2.946

Table 3 shows the average movement of CVC tip from initial location depending on the patient’s BMI and change in position during hospitalization using the linear regression model.

When comparing tip position and movement for CVCs inserted in the ICU and the CVICU departments, a significant difference in the initial tip position was identified with an average of- 2.1 cm below the carina in ICU patients vs 0.9 cm below the carina in CVICU patients (P_value = 0.001). In the ICU, 41% of CVCs were initially well-position compared to 50% in the CVICU (P_value 0.315), while both units use the same 15 cm long CVC. No significant change in tip migration was identified (1.95 cm for ICU and 1.85 cm for CVICU, P_value 0.64).

No CVC-related complications were recognized in the post insertion CXR and none of the CVCs were repositioned after the first insertion.

Discussion

Although CVC insertion is a common procedure, an optimal CVC tip location definition is still a matter of debate that vary between recommendations [10]. Most literature and recommendations discuss initial positioning of the CVC, without addressing the indications and risks for repositioning. Moreover, CVC tip location immediately post insertion and during different stages of its use are of the same meaning, but knowledge of the tip migration, it’s significance and the need for follow up, lacks.

In this study, we set to examine the movement of CVC tip throughout its use. We examined both the range of movement between each two consecutive CXRs (usually a day apart), and the likelihood of CVC tip to remain within a narrow range as recommended in previous literature [1, 11]. We have learned that 1) after insertion, about half the catheters were outside the “narrow” range. 2) There was a significant average movement of 1.9 (±1) cm (mean±SD) of the CVC tip from initial position and 3) Initial optimal CVC location cannot predict correct positioning of CVC during the first days of hospitalization.

Based on these results, targeting a narrow range as a desirable catheter position [1, 11] may be challenging, as catheters will migrate in and out of that zone, while the significance and the need to manage that are questionable. Should a wider range approach be taken [1315], tip location will most likely be initially located and remain within that zone. Regarding the safety of using a large range for CVC positioning, a relationship has been shown between CVC position and catheter-related thrombosis, tamponade, and arrhythmias, but these are rare complications, mainly related to catheters positioned higher than the SVC or deep within the right atrium [1, 18]. Following insertion, assessment of the tip position using CXR is widely used in Intensive Care Units as a mandatory practice (although different recommendations for operating theatre settings exist [21]). This method, although commonly used, has been repeatedly questioned [7, 19]. With the growing use of US, CVC positioning remains the main indication for performing CXR prior to its use [7, 22]. For all of these issues, our data shows that using a 15cm long catheters with US-guided RIJ approach will result in most cases (adults with BMI<40 and height >155 cm) in positioning of the CVC within the SVC or at the upper part of the right atrium and will remain there during hospitalization.

Routine CXR for CVC assessment as a mandatory step before initiating it’s use, potentially affects patient care, mainly by delaying care [6, 19]. Extreme ICU environment such as the COVID pandemic can potentially increase delays. In addition, there are contradicting recommendations as to the necessity of action when a nonoptimal CVC tip is diagnosed, as repositioning of the CVC can lead to unnecessary patient discomfort and more complications (mainly infection), which may be more common and severe than complications from suboptimal tip position [23, 24]. Because of the relatively low incidence of complications, our study was not large enough nor was it targeted to discuss safety ((in our study no adverse effects were recorded), and further studies with larger cohorts are needed. Nevertheless, a wider range is well described in the literature [8].

In this study, we did not find a precise way to predict the movement of CVCs during their use. Although BMI was found to be a significant factor in CVC tip movement, it provides only a partial explanation of the diversity between patients, as other factors such as the X-ray angle and patient’s position might be involved. It has also been shown that a 1–5 cm movement of tip location can be related to patient’s head maneuvers [25]. Alternative methods of demonstrating tip position using US have been described [6, 26], though these methods are not routinely used.

Given the high probability that CVC tip will be within the SVC or at the upper part of the right atrium together with the unpredictability of CV movement during hospitalization, assessing the exact initial positioning after insertion has limited significance. Therefore, in selective cases when use of CVC is urgent, routine CXR might be used as earliest as possible but without delaying treatment.

In our facility, CVC insertion is performed mostly in two different settings; in the ICU, CVCs are inserted bedside, using a US-guided technique, by a trained physician and a routine CXR is mandatory before the use of the CVC. In the operation theatre, CVCs are inserted (before heart surgeries etc.), by similarly trained physicians, but CXR is performed only after surgery is done, in the CVICU (hours after insertion). When comparing between ICU and CVICU, there was a significant difference in CVC position post insertion, while movement of the tip during hospitalization was similar. Differences in the position between these scenarios may be secondary to the different time interval and manipulations between insertion and CXR. Because the difference in the initial tip position is less than the average tip migration, these differences are probably without any clinical importance.

Our study’s limitations relate to the nature of CXR performed in the ICU/CVICU units; using a mobile x-ray machine while the patient is in a supine position can lead to reduced CXR quality and difficult analysis. This was the case in around 15% of CXRs observed and an additional examination by an ICU attending was needed. Another limitation of this study is the variability in tip positioning caused by the patient’s head position during CXR and anatomical variants which were not measured during the study. These factors and limitations exist in the “every day” ICU settings and present a challenge for the clinician in every tip position assessment after CVC insertion, therefore they do not weaken this study’s conclusions, but rather reflect the daily routine. Another limitation was that CVCs were inserted by different physicians from different departments. We believe this had only a little effect, as all were ICU or Anaesthesia physicians with similar training working under the same guidelines. Finally, the size of the study group did not allow us to assess the rate of complications and relationship to different locations of the catheter tip or its migration, a larger study is needed to address this issue.

Conclusions

CVC tip position migrates throughout its use, thus an initial optimal position within a narrow range does not reflect or predict its position later during treatment. Should a wider range of tip position be accepted, a 15 cm CVC inserted through the RIJ in most adults with height over 155 cm and BMI<40 will initially reside within the SVC or top right atrium and remain in that location throughout its use.

Supporting information

S1 Data. Publication data.

(XLSX)

Data Availability

All relevant data are within the paper and its Supporting information files.

Funding Statement

The author(s) received no specific funding for this work.

References

  • 1.Pittiruti M, Lamperti M. Late cardiac tamponade in adults secondary to tip position in the right atrium: An urban legend? A systematic review of the literature. Journal of Cardiothoracic and Vascular Anesthesia. 2015;29(2):491–495. doi: 10.1053/j.jvca.2014.05.020 [DOI] [PubMed] [Google Scholar]
  • 2.Tuinman PR, van de Ven PM, Smit JM, Petjak M, Blans MJ, Raadsen R. Bedside ultrasound to detect central venous catheter misplacement and associated iatrogenic complications: a systematic review and meta-analysis. Critical Care. 2018;22(1):1–15. doi: 10.1186/s13054-018-1989-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Saugel B, Scheeren TWL, Teboul JL. Ultrasound-guided central venous catheter placement: A structured review and recommendations for clinical practice. Critical Care. 2017;21(1):1–11. doi: 10.1186/s13054-017-1814-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Brass P, Hellmich M, Kolodziej L, Schick G, Smith AF. Ultrasound guidance versus anatomical landmarks for internal jugular vein catheterization. Cochrane Database of Systematic Reviews. Published online 2015. doi: 10.1002/14651858.CD006962.pub2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Hrdy O, Strazevska E, Suk P, et al. Central venous catheter-related thrombosis in intensive care patients—Incidence and risk factors: A prospective observational study. Biomedical Papers. 2017;161(4):369–373. doi: 10.5507/bp.2017.034 [DOI] [PubMed] [Google Scholar]
  • 6.Galante O, Slutsky T, Fuchs L, et al. Single-operator ultrasound-guided central venous catheter insertion verifies proper tip placement. Critical Care Medicine. 2017;45(10):e994–e1000. doi: 10.1097/CCM.0000000000002500 [DOI] [PubMed] [Google Scholar]
  • 7.Hourmozdi JJ, Markin A, Johnson B, Fleming PR, Miller JB. Routine Chest Radiography Is Not Necessary after Ultrasound-Guided Right Internal Jugular Vein Catheterization. Critical Care Medicine. 2016;44(9):e804–e808. doi: 10.1097/CCM.0000000000001737 [DOI] [PubMed] [Google Scholar]
  • 8.Geerts W. Central venous catheter-related thrombosis. Hematology. 2014;2014(1):306–311. doi: 10.1182/asheducation-2014.1.306 [DOI] [PubMed] [Google Scholar]
  • 9.Shamir MY, Bruce LJ. Central Venous Catheter-Induced Cardiac Tamponade. Anesthesia & Analgesia. 2011;112(6):1280–1282. doi: 10.1213/ane.0b013e318214b544 [DOI] [PubMed] [Google Scholar]
  • 10.Vesely TM. Central venous catheter tip position: A continuing controversy. Journal of Vascular and Interventional Radiology. 2003;14(5):527–534. doi: 10.1097/01.rvi.0000071097.76348.72 [DOI] [PubMed] [Google Scholar]
  • 11.Frykholm P, Pikwer A, Hammarskjöld F, et al. Clinical guidelines on central venous catheterisation. Acta Anaesthesiologica Scandinavica. 2014;58(5):508–524. doi: 10.1111/aas.12295 [DOI] [PubMed] [Google Scholar]
  • 12.Jayaraman J, Shah V. Bedside prediction of the central venous catheter insertion depth—Comparison of different techniques. Journal of Anaesthesiology Clinical Pharmacology. 2019;35(2):197–201. doi: 10.4103/joacp.JOACP_125_16 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Stonelake PA, Bodenham AR. The carina as a radiological landmark for central venous catheter tip position. British Journal of Anaesthesia. 2006;96(3):335–340. doi: 10.1093/bja/aei310 [DOI] [PubMed] [Google Scholar]
  • 14.Kwon HJ, Yil Jeong, Jun IG, Moon YJ, Lee YM. Evaluation of a central venous catheter tip placement for superior vena cava-subclavian central venous catheterization using a premeasured length. Medicine (United States). 2018;97(2):1–4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Marino PL. The ICU Book 4th Edition. 2015;1:44–48. [Google Scholar]
  • 16.Czepizak, O’Callaghan JM, Venus B. Evaluation of formulas for optimal positioning of central venous catheters. Chest. 1995;107(6). doi: 10.1378/chest.107.6.1662 [DOI] [PubMed] [Google Scholar]
  • 17.Joshi A, Bhosale G, Parikh G, Shah V. Optimal positioning of right-sided internal jugular venous catheters: Comparison of intra-atrial electrocardiography versus Peres’ formula. Indian Journal of Critical Care Medicine. 2008;12(1). doi: 10.4103/0972-5229.40943 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Parienti JJ, Mongardon N, Mégarbane B, et al. Intravascular Complications of Central Venous Catheterization by Insertion Site. New England Journal of Medicine. 2015;373(13). doi: 10.1056/NEJMoa1500964 [DOI] [PubMed] [Google Scholar]
  • 19.Maury E, Guglielminotti J, Alzieu M, Guidet B, Offenstadt G. Ultrasonic examination: An alternative to chest radiography after central venous catheter insertion? American Journal of Respiratory and Critical Care Medicine. 2001;164(3):403–405. doi: 10.1164/ajrccm.164.3.2009042 [DOI] [PubMed] [Google Scholar]
  • 20.Bodenham A, Babu S, Bennett J, et al. Association of Anaesthetists of Great Britain and Ireland: Safe vascular access 2016. Anaesthesia. 2016;71(5):573–585. doi: 10.1111/anae.13360 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Parameters P. Practice Guidelines for Central Venous Access 2020: An Updated Report by the American Society of Anesthesiologists Task Force on Central Venous Access. Vol 132.; 2020. [DOI] [PubMed]
  • 22.Vallecoccia M, Cavallaro F, Biancone M, et al. Is chest X-ray necessary after central venous catheter insertion? Critical Care. Published online 2014. doi: 10.1186/cc13319 [DOI] [Google Scholar]
  • 23.Frasca D, Dahyot-fizelier C, Mimoz O. Prevention of central venous catheter-related infection in the intensive care unit. Published online 2010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.McGee DC, Gould MK. Preventing Complications of Central Venous Catheterization. New England Journal of Medicine. 2003;348(12):1123–1133. doi: 10.1056/NEJMra011883 [DOI] [PubMed] [Google Scholar]
  • 25.Curelaru I, Linder LE, Gustavsson B. Displacement of catheters inserted through internal jugular veins with neck flexion and extension—A preliminary study. Intensive Care Medicine. Published online 1980. doi: 10.1007/BF01757300 [DOI] [PubMed] [Google Scholar]
  • 26.Weekes AJ, Johnson DA, Keller SM, et al. Central Vascular Catheter Placement Evaluation Using Saline Flush and Bedside Echocardiography. Academic Emergency Medicine. Published online 2013:65–72. doi: 10.1111/acem.12283 [DOI] [PubMed] [Google Scholar]

Decision Letter 0

Martin Kieninger

14 Jul 2022

PONE-D-22-14765Assessing Central Venous Catheter tip location- a different approach?PLOS ONE

Dear Dr. Merin,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Aug 28 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Martin Kieninger

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please delete it from any other section.

3. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. 

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: No

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: No

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Dear authors,

thank you for submitting your article and data. I believe that the article needs some major revision to clarify the message for the readers. I hope that my suggestions help you to improve your article.

Major concerns:

The title of your work suggests that you present a new/different approach to controlling catheter location with x-rays. But, you do not! Instead, you investigate catheter migration over time with consecutive x-rays. Choose an appropriate title.

In the discussion section, you write: …..examine the movement of CVC tip throughout its use. Exactly, this should be reflected in the title.

Follow up is 72 hours? Why? You state that every x-ray was evaluated in the method section. Why did you only use a 72 hour follow up as mentioned in the abstract and figure 3 and 4?

Material and Method

Clarify, how patients were included into the study. Do you have a database. Did you screen your PDMS, etc. for every patient admitted between xxx and xxx?

The exclusion criteria are documented sufficiently.

How was the mentioned distance between carina and catheter tip measured? Did you use a software? Did you use a x-ray fluoroscope/screen? A difference between tow investigators of more than 1 cm is mentioned – this seems large using a software?

Who are the investigators? Part of your study team or part of the wards? What was there training? How did the training of the ICU specialist differ how was consulted in case of poor x-ray quality? Did you check with radiology?

Statistics. You used a T-test. Did you check for normal distribution? If data does not show normal distribution a non-parametric test should be used.

The multi-parameters regression model used in table 3 has to be explained in the method section.

Results and Discussion

Major influencing factors of possible catheter mobilizations are not investigated or mentioned; e.g. prone positioning, mobilization of patients, insertion duration of the catheters, etc. If these data are not available, it should at least be discussed as limitation.

Adverse events/e.g. the non-existence of adverse events is not mentioned or discussed. Not one catheter had to be removed (even the one in the subclavian vein)?

Conclusions

You only included 101 patients. Relativize your conclusion: ….. a 15 cm CVC inserted through the RIJ in most adults will likely initially reside ….. Refer to the height and weight of the studied patients.

General

I suggest to revise the paper. Focus on your major statement: catheters may move by several centimeters of the course of time (with or without major adverse events???).

Include data to these observed/non-observed adverse events? After all, what does the catheter movement mean for our patients/clinical practice?

Minor concerns

Abstract:

Design and Settings: Retrospective, single-center study, conducted in the Intensive Care and Cardiovascular Intensive Care Units between January and June 2019….

- State the name of the hospital/institution here including city and country

The average initial tip position was 1.52 (±1.9)…..

- Clarify, you probably refer to mean ± SD

Central Venous Catheterization (CVC) is a common procedure in intensive care units (ICU),

operating rooms (OR), and other hospital departments.

- Specify ‘other hospital departments’ or give examples ‘other departments like…..’ or delete.

….a routine chest XRay (CXR) is obtained after insertion and before using the CVC in order to detect insertion related complications and to assess catheter tip position (CTP).

- Really? One x-ray after insertion and a new one before use? How long do you wait until you use newly inserted CVCs in your ICU?

In addition, the use of bedside-US has been shown to be faster and more accurate in detecting these complications when they occur.

- Specify, faster than what else (x-rays)?

CTP

- You already use CVC as abbreviation. I suggest to use only CVC and refer to the ‘tip of the CVC’, since both abbreviations are similar.

….performing US assisted or guided CVC insertion

- Clarify. What is the difference?

…m the upper part of the SVC to the right atrium10,13–19 (Zone A and B).

- Clarify, Zone A and B as depicted in figure xxx.

All data were analysed by SPSS version 21.0.

- Suggestion: All data were analysed using SPSS version 21.0.

At each follow-up CXR, the chance of an initially well-positioned and initially malpositioned catheter to be in the "safezone" were similar (48% vs 39% at first CXR, 49% vs 26% at second and 40% vs 50% at third CXR.

- Do not use ‘safezone’, use the terminology introduced above. You refer to similar, but I do not see a statistical evaluation. If a descriptive approach was used it has to be explained in the method section.

We examined both the range of daily movement…

- No! Do you perform routine daily x-rays on your ICU? If so, explain in the method section. This would contribute to the work. Explain, when follow up x-rays were taken.

There was a significant average movement of was 1.9 (±1) cm of CTP and thus predicting accurately the tip position (within a narrow range) is limited.

- Does not make sense. Clarify. Of course, one cannot predict a future positioning because of a current exact position.

Reviewer #2: This manuscript is a retrospective study on assessing the migration of the tip of IVC in hospitalized patients. The authors have concluded that the tip of CVC can migrate throughout patients’ hospitalization course, but “will remain within a wide range of the top of the right atrium and the middle of the Superior Vena Cava (SVC), if accepted as well-positioned”.

In terms of the originality of the article, there have been descriptions of several cases of catheter migration, but I could not find any prospective or retrospective studies in this area.

The title of this manuscript could be changed, it should be more explanatory of the study itself. Please, consider changing the title. The abstract portion of the manuscript clearly reflects its content.

In results in Table 2, please specify the descriptions. If catheter was malpositioned since initial placement, how you can make a column of “Well-positioned catheter”. Consider revising.

In the discussion, you should also add several limitations of the study secondary to its retrospective origin:

1. Even though catheters were placed by two teams of providers, there is a necessity to mention that difference in providers skills should be a consideration

2. There was no mention of how the CVCs were secured in place. That also might add to a higher or lower possibility of migration, depending on how CVCs were secured and dressings applied.

In conclusion, I would recommend this Manuscript for publication with the change of the title and minor correction as I mentioned above.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: Eugenia Ayrian, MD

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2022 Dec 19;17(12):e0277618. doi: 10.1371/journal.pone.0277618.r002

Author response to Decision Letter 0


10 Aug 2022

This is a revised version of our manuscript after addressing and correcting the reviewers’ extensive and constructive comments.

Attaches is a point-by-point response and description of all changes to the manuscript (a version of the manuscript with highlighted changes is also attached).

Attachment

Submitted filename: Response to Reviewers.docx

Decision Letter 1

Martin Kieninger

8 Sep 2022

PONE-D-22-14765R1Central catheter tip migration in critically ill patientsPLOS ONE

Dear Dr. Merin,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Oct 23 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Martin Kieninger

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: (No Response)

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Dear authors,

thank you for accepting the suggestions.

Some of the revised scentences are hard to read:

Another limitation rests with the retrospective origin of the trail- CVC's were inserted

by different physicians, and although all were ICU or Anaesthesia physicians with similar

training working under the same guidelines, of nature each have different skill that were not

taken into account.

-> Please, consider to break it down.

Some typos 'sneaked' into the revised version:

... with hight over 155 cm and BMI<40....

-> Should be: height

The article needs to be checked for typos and akward phrasing before publication.

Reviewer #2: Please make minor changes to the manuscript:

Materials and methods: -"Patients under the age of 18, hospitalized less than 24 hours, prone position, pregnant individuals..." - Add ‘Patients in' prone position...

-“After proving normality“ - please revise

Table 2: when describe the “Malpositioned CVCs” you have to change the name of “Well-positioned tip”, since there is no well-positioned tip in mal-positioned catheters. You possibly mean that the catheter tip was not migrated from initial malposition, but it is not well understood from the description - revise.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2022 Dec 19;17(12):e0277618. doi: 10.1371/journal.pone.0277618.r004

Author response to Decision Letter 1


5 Oct 2022

We would like to thank you again for the constructive comments. All of the reviewer's comments were asnwered and corrected as shown in the attached respons letter.

We believe the manuscriped had improved due to the reviewers’ thoughtful and constructive comments and suggestions for revision.

Attachment

Submitted filename: Response to Reviewers.docx

Decision Letter 2

Martin Kieninger

1 Nov 2022

Central catheter tip migration in critically ill patients

PONE-D-22-14765R2

Dear Dr. Merin,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Martin Kieninger

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: In the method section you wrote:

Data was proved for normal distribution before performing T-test.

It should be:

Data was tested for normal distribution before performing a T-test. (or: Normal distribution was proven before performing a T-test.)

Reviewer #2: Thank you for accepting my suggestions. I am satisfied with all changes. Manuscript can be published

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

Acceptance letter

Martin Kieninger

9 Dec 2022

PONE-D-22-14765R2

Central catheter tip migration in critically ill patients

Dear Dr. Merin:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Martin Kieninger

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Data. Publication data.

    (XLSX)

    Attachment

    Submitted filename: Response to Reviewers.docx

    Attachment

    Submitted filename: Response to Reviewers.docx

    Data Availability Statement

    All relevant data are within the paper and its Supporting information files.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES